Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
5512.84%
↑ 825% above average
Average (9y)
596.28%
Historical baseline
Range
High:5512.84%
Low:-97.83%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 5512.84% |
| 2023 | -97.83% |
| 2022 | 13.64% |
| 2021 | -57.92% |
| 2020 | 12.29% |
| 2019 | 1.86% |
| 2018 | 93.76% |
| 2017 | -37.20% |
| 2016 | 550.83% |
| 2015 | -29.47% |